EUVIMEDEUVIMED entdecken
Crossref

Development of D–A–D‐Type NIR‐II Photothermal Agents for Synergistic Eradication of Multidrug‐Resistant Bacteria and Promoting Diabetic Wound Healing

Ji Liu, Yuxin Wang, Weijie Gao, Mingyi Cao, Haojun Bian, Shiya Wang, Lijuan Gui, Changhui Zhao, Yueqing Gu, Qifeng Zhong, Jinrong Zheng, Li Zhang und 1 weitere

Advanced Functional Materials · 2025-01 · 35 (1)

DOI: 10.1002/adfm.202411986 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 29.08.2024. Verfasst von Ji Liu und 12 weiteren Autor:innen. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The challenge in treating diabetic foot infections caused by drug‐resistant bacteria is rapidly eradicating bacteria and accelerating wound healing. NIR‐II‐induced photothermal therapy (PTT) offers notable advantages over conventional treatments, such as broad‐spectrum bactericidal efficacy, better penetration depth in biological tissues, and higher skin tolerance thresholds, making it particularly suitable for addressing diabetic foot infections. Herein, it is found that NIR‐II dye IR26 exhibited good photothermal effects but poor photothermal stability. By modifying IR26 with methoxy and triphenylamine groups, a novel D–A–D‐type NIR‐II small molecule photothermal agent (IRC) is developed, with high photothermal stability and photothermal conversion efficiency (44.3%). IRC exhibited a maximum absorption wavelength of 1166 nm and a maximum emission wavelength of 1238 nm. However, PTT alone cannot effectively promote diabetic wound healing. Therefore, a novel nanoplatforms (Cur‐IRC@PCM) are developed by coloading IRC and curcumin, a natural wound–healing compound, into thermosensitive liposomes to treat MRSA‐infected diabetic wounds. Under 980 nm laser irradiation, Cur‐IRC@PCM provided PTT and controlled the precise release of curcumin, effectively synergizing to eradicate drug‐resistant bacteria and accelerate wound closure. The intelligent antibacterial nanoplatforms Cur‐IRC@PCM also exhibits excellent biocompatibility, rendering it a promising therapeutic tool in biomedical fields for combating drug‐resistant bacterial infections.

Förderung

  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Liu, J., Wang, Y., Gao, W., Cao, M., Bian, H., Wang, S., Gui, L., Zhao, C., Gu, Y., Zhong, Q., Zheng, J., Zhang, L., & Yuan, Z. (2025). Development of D–A–D‐Type NIR‐II Photothermal Agents for Synergistic Eradication of Multidrug‐Resistant Bacteria and Promoting Diabetic Wound Healing. Advanced Functional Materials, 35(1). https://doi.org/10.1002/adfm.202411986

Vancouver

Liu J, Wang Y, Gao W, Cao M, Bian H, Wang S, et al. Development of D–A–D‐Type NIR‐II Photothermal Agents for Synergistic Eradication of Multidrug‐Resistant Bacteria and Promoting Diabetic Wound Healing. Advanced Functional Materials. 2025;35(1). doi:10.1002/adfm.202411986

BibTeX
@article{Liu2025,
  author = {Liu, Ji and Wang, Yuxin and Gao, Weijie and Cao, Mingyi and Bian, Haojun and Wang, Shiya and Gui, Lijuan and Zhao, Changhui and Gu, Yueqing and Zhong, Qifeng and Zheng, Jinrong and Zhang, Li and Yuan, Zhenwei},
  title = {Development of D–A–D‐Type NIR‐II Photothermal Agents for Synergistic Eradication of Multidrug‐Resistant Bacteria and Promoting Diabetic Wound Healing},
  journal = {Advanced Functional Materials},
  year = {2025},
  volume = {35},
  number = {1},
  doi = {10.1002/adfm.202411986}
}
Kostenlos starten →